Trials / Recruiting
RecruitingNCT06494033
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients
Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients: a Single Center Prospective Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- University of Miami · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the clinical outcomes of Cytomegalovirus (CMV) virus in the participants' body. Therefore, the study team will follow the participants' immunological response based on the Cytomegalovirus (CMV) virus testing.
Conditions
Timeline
- Start date
- 2024-07-03
- Primary completion
- 2026-12-30
- Completion
- 2026-12-30
- First posted
- 2024-07-10
- Last updated
- 2026-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06494033. Inclusion in this directory is not an endorsement.